What did SenesTech CEO Michael Edell do on July 7, 2026, and how did it affect his total direct shareholding?

On July 7, 2026, SenesTech CEO Michael Edell purchased 1,000 shares of the company's common stock for $1,429, increasing his direct holdings to 5,000 shares.

Why might Michael Edell's stock purchase be seen as a signal of confidence, according to the news body?

The news body states that SenesTech's stock is 'currently trading near its 52-week low and is considered undervalued by InvestingPro analysis', while the company recently reported a 2% revenue increase and expanded its market reach with Evolve Rodent Birth Control products — suggesting the purchase may reflect confidence in the company's fundamentals and growth trajectory despite depressed share price.

SenesTech CEO Michael Edell Buys $1,429 in Company Stock

Jul 8, 2026

SenesTech CEO Michael Edell purchased 1,000 shares, increasing holdings to 5,000, while the company reported 2% revenue growth and expanded market reach for its Evolve Rodent Birth Control products.

Investing.com Canada

2026-05-07

SenesTech Appoints Michael Edell as President and Chief Executive Officer to Drive Revenue Growth and Scalable Sales Channels

2026-05-07

SenesTech Names Michael Edell as President and CEO

2026-05-07

SenesTech Appoints Michael Edell as CEO with 5% Equity Option Grant

2026-05-12

SenesTech Reports Record Direct-to-Consumer and Subscription Growth Following Strategic E-Commerce Transition

2026-05-12

SenesTech Reports Q1 Revenue Up 2%, Appoints New CEO